Distribution of Myofibroblast Cells and Microvessels Around Invasive Ductal Carcinoma of the Breast and Comparing with the Adjacent Range of Their Normal-to-DCIS Zones
Overview
Authors
Affiliations
Background: This study seeks to determine the relationships between manifestation of myofibroblasts in the stroma tissue of hyperplastic pre-invasive breast lesions to invasive cancer by investigating clinicopathological data of patients, their effect on steroid receptor expression and HER2, and angiogenesis according to CD34 antigen expression.
Methods: 100 cases of invasive ductal carcinoma were immunohistochemically investigated for the presence of smooth muscle actin (SMA), ER/PR, HER2, anti-CD34 antibody and microvessel count (MVC). Patients were scored in four different zones of invasive areas: invasive cancer, DCIS, fibrocystic disease ± ductal intraepithelial neoplasia (FCD ± DIN), and normal tissue.
Results: There was a significant difference in stromal myofibroblasts between all areas except for the stroma of DCIS and FCD ± DIN (P < 0.001). We observed positive significant correlations between stromal myofibroblasts, HER2 expression, and the numbers of involved lymph nodes in invasive cancer, DCIS, and FCD ± DIN (P < 0.001). More myofibroblasts were present in grade III cases, with the least frequent observed among grade I cases in the stroma of those with invasive disease, DCIS, and FCD ± DIN (P < 0.001). MVC was inversely related to stromal myofibroblasts in invasive cancer (P < 0.001) and DCIS (P < 0.001), whereas there was a positive correlation in the stroma of FCD ± DIN (P = 0.002) and normal areas (P = 0.054). There was a significant difference in MVC observed in all areas except for DCIS and FCD ± DIN (P < 0.001). We noted significant inverse correlations between MVC, HER2 expression, and the numbers of involved lymph nodes in invasive cancer and DCIS (P < 0.001). Most MVC were present in grade I, with the least frequent observed in grade III cases in the stroma of invasive cancer, DCIS and FCD ± DIN (P < 0.001).
Conclusion: Angiogenesis can be observed before any significant myofibroblastic changes in the pre-invasive breast lesions. The elevated content of myofibroblasts in stroma of tumor; probably may be a worse prognostic factor and the steps from atypical epithelial hyperplasia to DCIS and then to the invasive carcinoma do not appear to be always part of a linear progression.
Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression.
Xu H, Lien T, Bergholtz H, Fleischer T, Djerroudi L, Vincent-Salomon A Front Genet. 2021; 12:670749.
PMID: 34149812 PMC: 8209521. DOI: 10.3389/fgene.2021.670749.
Klimov S, Miligy I, Gertych A, Jiang Y, Toss M, Rida P Breast Cancer Res. 2019; 21(1):83.
PMID: 31358020 PMC: 6664779. DOI: 10.1186/s13058-019-1165-5.
Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A, Granato G, Ruocco M, Romano V, Belviso I, Carfora A Biomed Res Int. 2018; 2018:6075403.
PMID: 29967776 PMC: 6008683. DOI: 10.1155/2018/6075403.
Mesenchymal-epithelial signalling in tumour microenvironment: role of high-mobility group Box 1.
Sharma S, Evans A, Hemers E Cell Tissue Res. 2016; 365(2):357-66.
PMID: 26979829 PMC: 4943978. DOI: 10.1007/s00441-016-2389-7.
Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go.
Buchsbaum R, Oh S Cancers (Basel). 2016; 8(2).
PMID: 26828520 PMC: 4773742. DOI: 10.3390/cancers8020019.